AVI BioPharma gets FDA OK for Marburg virus drug
AVI BioPharma Inc. said it's received Food and Drug Administration approval to continue testing a single drug aimed at treatment of Marburg virus infection. Marburg virus is a severe and potentially...
View ArticleOncoGenex raises $46.8M in offering; shares dip
OncoGenex Pharmaceuticals Inc. said it's raised $46.8 million in an offering of 4.165 million shares of its stock. The Bothell biotech said it priced the shares at $12 each and underwriters have 30...
View ArticleFujifilm completes $995M purchase of SonoSite
Japanese film company Fujifilm has completed its purchase of portable ultrasound maker SonoSite Inc. of Bothell for $995 million. SonoSite shares (NASDAQ: SONO) will no longer be traded on the NASDAQ...
View ArticleAVI BioPharma: Longer test needed for muscular dystrophy drug
AVI BioPharma Inc. said a study of its eteplirsen drug for boys with Duchenne muscular dystrophy (DMD) "met the primary efficacy endpoint" but added a longer study will be needed. A 12-week study "did...
View ArticleSeattle Genetics pares Q1 loss, stock slips
Seattle Genetics Inc. reported a first-quarter loss of $12.3 million, or a loss of 11 cents per share, which compares with a loss of $32.7 million, or a loss of 30 cents per share a year earlier. The...
View ArticleMarina Biotech stops most day-to-day operations
Marina Biotech Inc., the Bothell company that was concentrating on developing RNA-based therapies for cancer, including bladder cancer, is shutting down most of its operations. In a press release,...
View ArticleSeattle Genetics prostate cancer drug trial results 'encouraging'
Seattle Genetics Inc. said the results of a trial for its drug targeting the treatment of castration-resistant prostate cancer were "encouraging." Bothell-based Seattle Genetics (NASDAQ: SGEN) is...
View ArticleMicrosoft, GE complete creation of Caradigm health-care company
Microsoft Corp. and General Electric Co. said they've completed the creation of their new health-care company — Caradigm — which will be located in City Center Bellevue. The two companies announced the...
View ArticleCardiac Science names new CEO
Cardiac Science Corp., the Bothell maker of automated external difibrillators and electrocardiac devices that was bought by Opto Circuits of India for about $55 million two years ago, has named Neal...
View ArticleAVI BioPharma changes name to Sarepta, splits stock
AVI BioPharma Inc. said it's changed its name to Sarepta Therapeutics Inc. and also enacted a one-for-six reverse stock split. The Bothell company said its shares will being trading (on a...
View ArticleSarepta says MD drug has 'significant' benefit; stock soars
Sarepta Therapeutics Inc., which used to be known as AVI BioPharma Inc., said a study of its eteplirsen treatment for patients with Duchenne muscular dystrophy (DMD) showed a "significant clinical...
View ArticleDeloitte Fast 500 recognizes 21 Northwest companies
The connections we make are critical to success in business, whether they be personal or professional. For the 18th year in a row, Deloitte is recognizing Washington state’s fastest-growing technology...
View Article
More Pages to Explore .....